Stunner AF system
Forecast Overview
- NAICS
- 334516
- Performance end
- 8/2026
FDA, Center for Biologics Evaluation and Research (CBER), has a requirement for an analytical system with advanced, integrated multi-attribute characterization platform to enable characterization of Adeno-Associated Virus (AAV) vectors and Lipid Nanoparticles (LNPs). The laboratory develops next-generation AAV vectors and evaluates their immunogenicity and quality attributes. A critical need is the ability to measure genome packaging efficiency (empty/full ratio), which is the most important CQA for AAV products. The instrument must simultaneously measure dynamic light scattering (DLS) for particle sizing, UV-Visible absorbance for concentration quantification, and fluorescence for encapsulation efficiency (EE%) determination - all from a single, low-volume (2 L) sample in a high-throughput plate-based format. The Unchained Labs Stunner AF system or equal system, will allow measurement of all four CQAs from a single 2 L sample in one run. The requirement also has four 1-year post-warranty service agreement options.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31
Related Federal Entities
- Department of Health and Human Services
- Imager Gbox Chemi (or equal) Gel Documentation System
- Cytation 9 Multimode Reader
- Acquisition of a new plate reader
- Next Generation Sequencing (NGS) device with post-warranty service agreement options
- Urinalysis Analyzer Backup
- Federal Technology Spending Map
- Federal Opportunity Research